The lymphatic biology of Kaposi's sarcoma

Lymphatic Research and Biology

Volumn 3, Issue 1, 2005, Pages 25-35

  Cheung, Lauren ^a   Rockson, Stanley G ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; CD34 ANTIGEN; COLLAGEN TYPE 4; LAMININ; LECTIN; VASCULOTROPIN C; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN RECEPTOR 3; VON WILLEBRAND FACTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BLOOD ANALYSIS; CELL TYPE; DISEASE ASSOCIATION; ENDEMIC DISEASE; GENE EXPRESSION; HERPES VIRUS INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INCIDENCE; KAPOSI SARCOMA; LYMPH VESSEL ENDOTHELIUM; LYMPHATIC SYSTEM DISEASE; PATHOGENESIS; POPULATION RESEARCH; PRIORITY JOURNAL; REVIEW; SARCOMA CELL; SURVIVAL RATE; VASCULAR ENDOTHELIUM; VIRUS TRANSMISSION;

HISTORY, 20TH CENTURY; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC SYSTEM; SARCOMA, KAPOSI;

EID: 15944393836     PISSN: 15396851     EISSN: None     Source Type: Journal    
DOI: 10.1089/lrb.2005.3.25     Document Type: Review

References (50)

1. Kaposi M. Idiopathisches multiples Pigmentsarkom der Haut. Archiv Dermatol Syphilis 1872;4:265-273.
2. Oettle AG. Geographical and racial differences in the frequency of Kaposi's sarcoma as evidence of environmental or genetic causes. Acta Unio Int Contra Cancrum 1962;18:330-363.
3. Buchbinder A, Friedman-Kien AE. Clinical aspects of epidemic Kaposi's sarcoma. Cancer Surv 1991;10: 39-52.
4. Friedman-Kien AE, Saltzman BR. Clinical manifestations of classical, endemic African, and epidemic AIDS-associated Kaposi's sarcoma. J Am Acad Dermatol 1990;22:1237-1250.
5. Moore PS. The emergence of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8). N Engl J Med 2000; 343:1411-1413.
6. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994;266:1865-1869.
7. Antman K, Chang Y. Kaposi's sarcoma. N Engl J Med 2000;342:1027-1038.
8. Moore PS, Chang Y. Kaposi's sarcoma (KS), KS-associated herpesvirus, and the criteria for causality in the age of molecular biology. Am J Epidemiol 1998;147: 217-221.
9. Pauk J, Huang ML, Brodie SJ, Wald A, Koelle DM, Schacker T, Celum C, Selke S, Corey L. Mucosal shedding of human herpesvirus 8 in men. N Engl J Med 2000;343:1369-1377.
10. Jones RR, Spaull J, Spry C, Jones EW. Histogenesis of Kaposi's sarcoma in patients with and without acquired immune deficiency syndrome (AIDS). J Clin Pathol 1986;39:742-749.
11. Beckstead JH, Wood GS, Fletcher V. Evidence for the origin of Kaposi's sarcoma from lymphatic endothelium. Am J Pathol 1985;119:294-300.
12. Rutgers JL, Wieczorek R, Bonetti F, Kaplan KL, Posnett DN, Friedman-Kien AE, Knowles DM, 2nd. The expression of endothelial cell surface antigens by AIDS-associated Kaposi's sarcoma. Evidence for a vascular endothelial cell origin. Am J Pathol 1986;122: 493-499.
13. Scully PA, Steinman HK, Kennedy C, Trueblood K, Frisman DM, Voland JR. AIDS-related Kaposi's sarcoma displays differential expression of endothelial surface antigens. Am J Pathol 1988;130:244-251.
14. Dictor M. Kaposi's sarcoma. Origin and significance of lymphaticovenous connections. Virchows Arch A Pathol Anat Histopathol 1986;409:23-35.
15. Jenner RG, Boshoff C. The molecular pathology of Kaposi's sarcoma-associated herpesvirus. Biochim Biophys Acta 2002;1602:1-22.
16. Jussila L, Valtola R, Partanen TA, Salven P, Heikkila P, Matikainen MT, Renkonen R, Kaipainen A, Detmar M, Tschachler E, Alitalo R, Alitalo K. Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3. Cancer Res 1998;58:1599-1604.
17. Green TL, Meyer JR, Daniels TE, Greenspan JS, de Souza Y, Kramer RH. Kaposi's sarcoma in AIDS: basement membrane and endothelial cell markers in latestage lesions. J Oral Pathol 1988;17:266-272.
18. Uccini S, Ruco LP, Monardo F, Stoppacciaro A, Dejana E, La Parola IL, Cerimele D, Baroni CD. Co-expression of endothelial cell and macrophage antigens in Kaposi's sarcoma cells. J Pathol 1994;173:23-31.
19. Appleton MA, Attanoos RL, Jasani B. Thrombomodulin as a marker of vascular and lymphatic tumours. Histopathology 1996;29:153-157.
20. Sauter B, Foedinger D, Sterniczky B, Wolff K, Rappersberger K. Immunoelectron microscopic characterization of human dermal lymphatic microvascular endothelial cells. Differential expression of CD31, CD34, and type IV collagen with lymphatic endothelial cells vs blood capillary endothelial cells in normal human skin, lymphangioma, and hemangioma in situ. J Histochem Cytochem 1998;46:165-176.
21. Nagle RB, Witte MH, Martinez AP, Witte CL, Hendrix MJ, Way D, Reed K. Factor VIII-associated antigen in human lymphatic endothelium. Lymphology 1987;20:20-24.
22. Nadimi H, Saatee S, Armin A, Toto PD. Expression of endothelial cell markers PAL-E and EN-4 and Ia-antigens in Kaposi's sarcoma. J Oral Pathol 1988;17: 416-420.
23. Nerlich A, Zietz C, Schleicher E. Distribution of basement membrane-associated heparan sulfate proteoglycan in idiopathic and AIDS-associated Kaposi's sarcoma. Pathol Res Pract 1991;187:444-450.
24. Dictor M, Andersson C. Lymphaticovenous differentiation in Kaposi's sarcoma. Cellular phenotypes by stage. Am J Pathol. 1988;130:411-7.
25. Autio-Harmainen H, Karttunen T, Apaja-Sarkkinen M, Dammert K, Risteli L. Laminin and type IV collagen in different histological stages of Kaposi's sarcoma and other vascular lesions of blood vessel or lymphatic vessel origin. Am J Surg Pathol. 1988;12: 469-476.
26. Masood R, Cai J, Zheng T, Smith DL, Naidu Y, Gill PS. Vascular endothelial growth factor/vascular permeability factor is an autocrine growth factor for AIDS-Kaposi sarcoma. Proc Natl Acad Sci USA 1997; 94:979-984.
27. Nakamura S, Murakami-Mori K, Rao N, Weich HA, Rajeev B. Vascular endothelial growth factor is a potent angiogenic factor in AIDS-associated Kaposi's sarcoma-derived spindle cells. J Immunol 1997;158: 4992-5001.
28. Cornali E, Zietz C, Benelli R, Weninger W, Masiello L, Breier G, Tschachler E, Albini A, Sturzl M. Vascular endothelial growth factor regulates angiogenesis and vascular permeability in Kaposi's sarcoma. Am J Pathol 1996;149:1851-1869.
29. Brown LF, Tognazzi K, Dvorak HF, Harrist TJ. Strong expression of kinase insert domain-containing receptor, a vascular permeability factor/vascular endothelial growth factor receptor in AIDS-associated Kaposi's sarcoma and cutaneous angiosarcoma. Am J Pathol 1996;148:1065-1074.
30. Joukov V, Pajusola K, Kaipainen A, Chilov D, Lahtinen I, Kukk E, Saksela O, Kalkkinen N, Alitalo K. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. Embo J 1996;15:290-298.
31. Skobe M, Brown LF, Tognazzi K, Ganju RK, Dezube BJ, Alitalo K, Detmar M. Vascular endothelial growth factor-C (VEGF-C) and its receptors KDR and flt-4 are expressed in AIDS-associated Kaposi's sarcoma. J Invest Dermatol 1999;113:1047-1053.
32. Weninger W, Partanen TA, Breiteneder-Geleff S, Mayer C, Kowalski H, Mildner M, Pammer J, Sturzl M, Kerjaschki D, Alitalo K, Tschachler E. Expression of vascular endothelial growth factor receptor-3 and podoplanin suggests a lymphatic endothelial cell origin of Kaposi's sarcoma tumor cells. Lab Invest 1999;79:243-251.
33. Marchio S, Primo L, Pagano M, Palestro G, Albini A, Veikkola T, Cascone I, Alitalo K, Bussolino F. Vascular endothelial growth factor-C stimulates the migration and proliferation of Kaposi's sarcoma cells. J Biol Chem 1999;274:27617-27622.
34. Kahn HJ, Bailey D, Marks A. Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas. Mod Pathol 2002;15:434-440.
35. Banerji S, Ni J, Wang SX, Clasper S, Su J, Tammi R, Jones M, Jackson DG. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol 1999;144:789-801.
36. Xu H, Edwards JR, Espinosa O, Banerji S, Jackson DG, Athanasou NA. Expression of a lymphatic endothelial cell marker in benign and malignant vascular tumors. Hum Pathol 2004;35:857-861.
37. Oliver G, Detmar M. The rediscovery of the lymphatic system: old and new insights into the development and biological function of the lymphatic vasculature. Genes Dev 2002;16:773-783.
38. Witte MH, Stuntz M, Witte CL. Kaposi's sarcoma. A lymphologic perspective. Int J Dermatol 1989;28:561-570.
39. Ruocco V, Schwartz RA, Ruocco E. Lymphedema: an immunologically vulnerable site for development of neoplasms. J Am Acad Dermatol 2002;47:124-127.
40. Schwartz RA, Cohen JB, Watson RA, Gascon P, Ahkami RN, Ruszczak Z, Halpern J, Lambert WC. Penile Kaposi's sarcoma preceded by chronic penile lymphoedema. Br J Dermatol 2000;142:153-156.
41. Dorfman RF. Kaposi's sarcoma: evidence supporting its origin from the lymphatic system. Lymphology 1988;21:45-52.
42. Moses AV, Jarvis MA, Raggo C, Bell YC, Ruhl R, Luukkonen BG, Griffith DJ, Wait CL, Druker BJ, Heinrich MC, Nelson JA, Fruh K. Kaposi's sarcoma-associated herpesvirus-induced upregulation of the c-kit proto-oncogene, as identified by gene expression profiling, is essential for the transformation of endothelial cells. J Virol 2002;76:8383-8399.
43. Wang HW, Trotter MW, Lagos D, Bourboulia D, Henderson S, Makinen T, Elliman S, Flanagan AM, Alitalo K, Boshoff C. Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma. Nat Genet 2004;36:687-693.
44. Hong YK, Foreman K, Shin JW, Hirakawa S, Curry CL, Sage DR, Libermann T, Dezube BJ, Fingeroth JD, Detmar M. Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma-associated herpesvirus. Nat Genet 2004;36:683-685.
45. Wigle JT, Harvey N, Detmar M, Lagutina I, Grosveld G, Gunn MD, Jackson DG, Oliver G. An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype. Embo J 2002; 21:1505-1513.
46. Petrova TV, Makinen T, Makela TP, Saarela J, Virtanen I, Ferrell RE, Finegold DN, Kerjaschki D, Yla-Herttuala S, Alitalo K. Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor. Embo J 2002;21:4593-4599.
47. Sugaya M, Watanabe T, Yang A, Starost MF, Kobayashi H, Atkins AM, Borris DL, Hanan EA, Schimel D, Bryant MA, Roberts N, Skobe M, Staskus KA, Kaldis P, Blauvelt A. Lymphatic dysfunction in transgenic mice expressing KSHV k-cyclin under the control of the VEGFR-3 promoter. Blood, Nov 2004; 10.1182/blood-2004-08-3364.
48. Facchetti F, Lucini L, Gavazzoni R, Callea F. Immunomorphological analysis of the role of blood vessel endothelium in the morphogenesis of cutaneous Kaposi's sarcoma: a study of 57 cases. Histopathology 1988;12:581-593.
49. Ostrowski ML, Siddiqui T, Barnes RE, Howton MJ. Vascular transformation of lymph node sinuses. A process displaying a spectrum of histologic features. Arch Pathol Lab Med 1990;114:656-660.
50. Uccini S, Sirianni MC, Vincenzi L, Topino S, Stoppacciaro A, Lesnoni La Parola I, Capuano M, Masini C, Cerimele D, Cella M, Lanzavecchia A, Allavena P, Mantovani A, Baroni CD, Ruco LP. Kaposi's sarcoma cells express the macrophage-associated antigen mannose receptor and develop in peripheral blood cultures of Kaposi's sarcoma patients. Am J Pathol 1997;150:929-938.